2 research outputs found

    NOTA Complexes with Copper(II) and Divalent Metal Ions: Kinetic and Thermodynamic Studies

    No full text
    H<sub>3</sub>nota derivatives are among the most studied macrocyclic ligands and are widely used for metal ion binding in biology and medicine. Despite more than 40 years of chemical research on H<sub>3</sub>nota, the comprehensive study of its solution chemistry has been overlooked. Thus, the coordination behavior of H<sub>3</sub>nota with several divalent metal ions was studied in detail with respect to its application as a chelator for copper radioisotopes in medical imaging and therapy. In the solid-state structure of the free ligand in zwitterionic form, one proton is bound in the macrocyclic cavity through a strong intramolecular hydrogen-bond system supporting the high basicity of the ring amine groups (log <i>K</i><sub>a</sub> = 13.17). The high stability of the [Cu­(nota)]<sup>−</sup> complex (log <i>K</i><sub>ML</sub> = 23.33) results in quantitative complex formation, even at pH <1.5. The ligand is moderately selective for Cu­(II) over other metal ions (e.g., log <i>K</i><sub>ML</sub>(Zn) = 22.32 and log <i>K</i><sub>ML</sub>(Ni) = 19.24). This ligand forms a more stable complex with Mg­(II) than with Ca­(II) and forms surprisingly stable complexes with alkali-metal ions (stability order Li­(I) > Na­(I) > K­(I)). Thus, H<sub>3</sub>nota shows high selectivity for small metal ions. The [Cu­(nota)]<sup>−</sup> complex is hexacoordinated at neutral pH, and the equatorial N<sub>2</sub>O<sub>2</sub> interaction is strengthened by complex protonation. Detailed kinetic studies showed that the Cu­(II) complex is formed quickly (millisecond time scale at <i>c</i><sub>Cu</sub> ≈ 0.1 mM) through an <i>out-of-cage</i> intermediate. Conversely, conductivity measurements revealed that the Zn­(II) complex is formed much more slowly than the Cu­(II) complex. The Cu­(II) complex has medium kinetic inertness (τ<sub>1/2</sub> 46 s; pH 0, 25 °C) and is less resistant to acid-assisted decomplexation than Cu­(II) complexes with H<sub>4</sub>dota and H<sub>4</sub>teta. Surprisingly, [Cu­(nota)]<sup>−</sup> decomplexation is decelerated in the presence of Zn­(II) ions due to the formation of a stable dinuclear complex. In conclusion, H<sub>3</sub>nota is a good carrier of copper radionuclides because the [Cu­(nota)]<sup>−</sup> complex is predominantly formed over complexes with common impurities in radiochemical formulations, Zn­(II) and Ni­(II), for thermodynamic and, primarily, for kinetic reasons. Furthermore, the in vivo stability of the [Cu­(nota)]<sup>−</sup> complex may be increased due to the formation of dinuclear complexes when it interacts with biometals

    Cyclam Derivatives with a Bis(phosphinate) or a Phosphinato–Phosphonate Pendant Arm: Ligands for Fast and Efficient Copper(II) Complexation for Nuclear Medical Applications

    No full text
    Cyclam derivatives bearing one geminal bis­(phosphinic acid), −CH<sub>2</sub>PO<sub>2</sub>HCH<sub>2</sub>PO<sub>2</sub>H<sub>2</sub> (H<sub>2</sub><b>L</b><sup><b>1</b></sup>), or phosphinic–phosphonic acid, −CH<sub>2</sub>PO<sub>2</sub>HCH<sub>2</sub>PO<sub>3</sub>H<sub>2</sub> (H<sub>3</sub><b>L</b><sup><b>2</b></sup>), pendant arm were synthesized and studied as potential copper­(II) chelators for nuclear medical applications. The ligands showed good selectivity for copper­(II) over zinc­(II) and nickel­(II) ions (log <i>K</i><sub>CuL</sub> = 25.8 and 27.7 for H<sub>2</sub><b>L</b><sup><b>1</b></sup> and H<sub>3</sub><b>L</b><sup><b>2</b></sup>, respectively). Kinetic study revealed an unusual three-step complex formation mechanism. The initial equilibrium step leads to <i>out-of-cage</i> complexes with Cu<sup>2+</sup> bound by the phosphorus-containing pendant arm. These species quickly rearrange to an <i>in-cage</i> complex with cyclam conformation <b>II</b>, which isomerizes to another <i>in-cage</i> complex with cyclam conformation <b>I</b>. The first <i>in-cage</i> complex is quantitatively formed in seconds (pH ≈5, 25 °C, Cu:L = 1:1, <i>c</i><sub>M</sub> ≈ 1 mM). At pH >12, <b>I</b> isomers undergo nitrogen atom inversion, leading to <b>III</b> isomers; the structure of the <b>III</b>-[Cu­(H<b>L</b><sup><b>2</b></sup>)] complex in the solid state was confirmed by X-ray diffraction analysis. In an alkaline solution, interconversion of the <b>I</b> and <b>III</b> isomers is mutual, leading to the same equilibrium isomeric mixture; such behavior has been observed here for the first time for copper­(II) complexes of cyclam derivatives. Quantum-chemical calculations showed small energetic differences between the isomeric complexes of H<sub>3</sub><b>L</b><sup><b>2</b></sup> compared with analogous data for isomeric complexes of cyclam derivatives with one or two methylphosphonic acid pendant arm(s). Acid-assisted dissociation proved the kinetic inertness of the complexes. Preliminary radiolabeling of H<sub>2</sub><b>L</b><sup><b>1</b></sup> and H<sub>3</sub><b>L</b><sup><b>2</b></sup> with <sup>64</sup>Cu was fast and efficient, even at room temperature, giving specific activities of around 70 GBq of <sup>64</sup>Cu per 1 μmol of the ligand (pH 6.2, 10 min, ca. 90 equiv of the ligand). These specific activities were much higher than those of H<sub>3</sub><b>nota</b> and H<sub>4</sub><b>dota</b> complexes prepared under identical conditions. The rare combination of simple ligand synthesis, very fast copper­(II) complex formation, high thermodynamic stability, kinetic inertness, efficient radiolabeling, and expected low bone tissue affinity makes such ligands suitably predisposed to serve as chelators of copper radioisotopes in nuclear medicine
    corecore